MedPath
Found 223 clinical trials|View Analysis
Sort by:

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

Phase 2
Not yet recruiting
Conditions
Stomach Neoplasms
Interventions
First Posted Date
2024-10-08
Last Posted Date
2024-10-16
Lead Sponsor
Jeeyun Lee
Target Recruit Count
50
Registration Number
NCT06630130

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Phase 2
Not yet recruiting
Conditions
Stomach Neoplasms
Immune Checkpoint Inhibitors
Interventions
Drug: Placebo combined with Chemotherapy
Drug: Serplulimab Combined With Chemotherapy
First Posted Date
2024-08-29
Last Posted Date
2024-08-29
Lead Sponsor
Xijing Hospital
Target Recruit Count
116
Registration Number
NCT06576921

A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis

Phase 2
Not yet recruiting
Conditions
Stomach Neoplasms
Interventions
First Posted Date
2024-08-21
Last Posted Date
2024-08-28
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
39
Registration Number
NCT06564298

Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients

Completed
Conditions
Stomach Neoplasms
Machine Learning
Gastrectomy
First Posted Date
2024-08-12
Last Posted Date
2024-08-12
Lead Sponsor
Chang-Ming Huang, Prof.
Target Recruit Count
18000
Registration Number
NCT06548464
Locations
🇨🇳

Chang-ming Huang, Fuzhou, Fujian, China

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer

Phase 2
Not yet recruiting
Conditions
Stomach Neoplasms
Solid Tumor
Interventions
Drug: IAH0968
First Posted Date
2024-07-17
Last Posted Date
2024-07-17
Lead Sponsor
SUNHO(China)BioPharmaceutical CO., Ltd.
Target Recruit Count
90
Registration Number
NCT06504732
Locations
🇨🇳

The First Hospital of China Medical University, Shenyang, Liaoning, China

Prediction Model for Advanced Gastric Cancer in Elderly

Completed
Conditions
Stomach Neoplasms
Aged
First Posted Date
2024-06-21
Last Posted Date
2024-06-21
Lead Sponsor
Chang-Ming Huang, Prof.
Target Recruit Count
1436
Registration Number
NCT06467591
Locations
🇨🇳

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer

Phase 2
Recruiting
Conditions
Stomach Neoplasms
Gastric Cancer
Linitis Plastica of Stomach
Interventions
First Posted Date
2024-06-11
Last Posted Date
2024-06-11
Lead Sponsor
Sun Yat-sen University
Target Recruit Count
53
Registration Number
NCT06451211
Locations
🇨🇳

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

Model for Prognosis of Elderly Gastric Cancer Patients

Completed
Conditions
Stomach Neoplasms
Aged
First Posted Date
2024-05-01
Last Posted Date
2024-05-01
Lead Sponsor
Chang-Ming Huang, Prof.
Target Recruit Count
1202
Registration Number
NCT06393153
Locations
🇨🇳

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Phase 1
Recruiting
Conditions
Advanced Solid Tumours
Squamous Cell Carcinoma of Head and Neck
Carcinoma, Non-Small-Cell Lung
Colorectal Neoplasms
Triple Negative Breast Neoplasms
Carcinoma, Renal Cell (Clear Cell Only)
Esophageal Neoplasms
Stomach Neoplasms (Excluding Gastrointestinal Stromal Tumors)
Uterine Cervical Neoplasms
Ovarian Neoplasms
Interventions
Drug: UCB4594
First Posted Date
2024-04-24
Last Posted Date
2024-08-20
Lead Sponsor
Cancer Research UK
Target Recruit Count
167
Registration Number
NCT06380816
Locations
🇬🇧

The Christie NHS Foundation Trust, Manchester, United Kingdom

🇬🇧

University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.

Not Applicable
Active, not recruiting
Conditions
Intestinal Neoplasms
Gastrointestinal Neoplasms
Stomach Neoplasms
Interventions
Device: Intermittent Pneumatic Compression Devices
First Posted Date
2024-02-15
Last Posted Date
2024-02-15
Lead Sponsor
Feng Tian
Target Recruit Count
120
Registration Number
NCT06260150
Locations
🇨🇳

Shandong Provincial Hospital, Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath